Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27946142 | 0.84 | HPGD (0.47) | HPGDPOLBSMN1; SMN2RAB9AKMT2A | |
| SCHEMBL10180539 | 0.83 | ALDH1A1 (0.33) | HPGDPOLBRAB9AKMT2AMEN1 | |
| SCHEMBL1720657 | 0.82 | KDM4E (0.41) | POLBRAB9AKMT2AMEN1MTNR1A | |
| SCHEMBL4815221 | 0.78 | TSHR (0.51) | HPGDPOLBSMN1; SMN2RAB9AKMT2A | |
| SCHEMBL1720572 | 0.77 | CYP1A2 (0.45) | SMN1; SMN2KMT2AMEN1MTNR1AMTNR1B | |
| SCHEMBL22524300 | 0.76 | TXNRD1 (0.32) | HPGDPOLBMTNR1AMTNR1B | |
| SCHEMBL4819062 | 0.76 | HPGD (0.48) | HPGDPOLBSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL7111143 | 0.74 | MTNR1A (0.39) | MTNR1AMTNR1BLMNA | |
| SCHEMBL7112159 | 0.72 | ALDH1A1 (0.35) | HPGDPOLBRAB9AKMT2AMEN1 | |
| SCHEMBL13197932 | 0.72 | TP53 (0.34) | SMN1; SMN2MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2674420-B1 | METHOD FOR PRODUCING AMINOPHENYL PYRIMIDINYL ALCOHOL DERIVATIVE, AND SYNTHESIS INTERMEDIATE THEREOF | IHARA CHEMICAL IND CO (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-20040199002-A1 | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | INDUSTRY CO., LTD. (JP) | 2004-10-07 | — | — | US | disclosed |
| EP-1431278-A1 | PROCESS FOR PRODUCING (2-NITROPHENYL)ACETONITRILE DERIVATIVE AND INTERMEDIATE THEREFOR | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2004-06-23 | — | — | EP | disclosed |
| EP-1361218-A1 | Trifluoromethanesulfonyl anilide derivatives, process for the preparation of them and herbicides containing them as the active ingredient | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2003-11-12 | — | — | EP | disclosed |
| EP-1101760-B1 | DIFLUOROMETHANESULFONYL ANILIDE DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND HERBICIDES CONTAINING THEM AS THE ACTIVE INGREDIENT | IHARA CHEMICAL IND CO (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-6458748-B1 | COMPOUND WHICH IS EFFECTIVE FOR THE REMOVAL OF A WIDE VARIETY OF WEEDS INCLUDING DIFFICULT-TO-CONTROL WEEDS EMERGING IN PADDY FIELD AND WHICH IS SAFE TO MAMMALS; A PROCESS FOR PRODUCTION THEREOF; A HERBICIDE CONTAINING THE COMPOUND AS AN | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2002-10-01 | — | — | US | disclosed |
| EP-1101760-A1 | DI- OR TRI-FLUOROMETHANESULFONYL ANILIDE DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND HERBICIDES CONTAINING THEM AS THE ACTIVE INGREDIENT | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2001-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040199002-A1 | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | DOHH, NCEH1, NOTUM | HPGD 90/4885POLB 1474/4885SMN1; SMN2 4072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.